Pozdnyakov A, Kulanthaivelu R, Bauman G, Ortega C, Veit-Haibach P, Metser U. The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00544-3.

Baas DJH, Schilham M, Hermsen R, et al. Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection. Prostate Cancer Prostatic Dis. 2022;25:65–70. https://doi.org/10.1038/s41391-021-00452-y.

CAS  Article  PubMed  Google Scholar 

Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–22. https://doi.org/10.1016/S0140-6736(16)32401-1.

Article  PubMed  Google Scholar 

Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767–77. https://doi.org/10.1056/NEJMoa1801993.

Article  PubMed  PubMed Central  Google Scholar 

Bertolo R, Vittori M, Cipriani C, et al. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized. Prog En Urol J Assoc Francaise Urol Soc Francaise Urol. 2021;31:739–46. https://doi.org/10.1016/j.purol.2020.12.008.

CAS  Article  Google Scholar 

Panebianco V, Barchetti G, Simone G, et al. Negative multiparametric magnetic resonance imaging for prostate cancer: what’s next? Eur Urol. 2018;74:48–54. https://doi.org/10.1016/j.eururo.2018.03.007.

Article  PubMed  Google Scholar 

Clinton TN, Bagrodia A, Lotan Y, Margulis V, Raj GV, Woldu SL. Tissue-based biomarkers in prostate cancer. Expert Rev Precis Med Drug Dev. 2017;2:249–60. https://doi.org/10.1080/23808993.2017.1372687.

Article  PubMed  PubMed Central  Google Scholar 

Raveenthiran S, Yaxley WJ, Franklin T, et al. Findings in 1123 men with preoperative 68ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: implications for the diagnosis and management of prostate cancer. J Urol. 2022;207:573–80. https://doi.org/10.1097/JU.0000000000002293.

CAS  Article  PubMed  Google Scholar 

Kalapara AA, Nzenza T, Pan HYC, et al. Detection and localisation of primary prostate cancer using 68 gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology. BJU Int. 2020;126:83–90. https://doi.org/10.1111/bju.14858.

CAS  Article  PubMed  Google Scholar 

Emmett L, Buteau J, Papa N, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography-computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol. 2021;80:682–9. https://doi.org/10.1016/j.eururo.2021.08.002.

CAS  Article  PubMed  Google Scholar 

Ferraro DA, Becker AS, Kranzbühler B, et al. Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single- center study. Eur J Nucl Med Mol Imaging. 2021;48:3315–24. https://doi.org/10.1007/s00259-021-05261-y.

Article  PubMed  PubMed Central  Google Scholar 

Koseoglu E, Kordan Y, Kilic M, et al. Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy. Prostate Cancer Prostatic Dis. 2021;24:202–9. https://doi.org/10.1038/s41391-020-00270-8.

CAS  Article  PubMed  Google Scholar 

Donato P, Roberts MJ, Morton A, et al. Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2019;46:20–30. https://doi.org/10.1007/s00259-018-4160-7.

Article  PubMed  Google Scholar 

von Klot CAJ, Merseburger AS, Böker A, et al. 68Ga-PSMA PET/CT imaging predicting intraprostatic tumor extent, extracapsular extension and seminal vesicle invasion prior to radical prostatectomy in patients with prostate cancer. Nucl Med Mol Imaging. 2017;51:314–22. https://doi.org/10.1007/s13139-017-0476-7.

CAS  Article  Google Scholar 

Pinaquy JB, De Clermont-Galleran H, Pasticier G, et al. Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer. Prostate. 2015;75:323–31. https://doi.org/10.1002/pros.22921.

CAS  Article  PubMed  Google Scholar 

Mottaghy FM, Heinzel A, Verburg FA. Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges? Eur J Nucl Med Mol Imaging. 2016;43:1397–9. https://doi.org/10.1007/s00259-016-3389-2.

Article  PubMed  Google Scholar 

Vlachostergios PJ, Niaz MJ, Thomas C, et al. Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer. Prostate 2022;82:483–92. https://doi.org/10.1002/pros.24294.Epub. 2022 Jan 5.

CAS  Article  PubMed  Google Scholar 

Roberts MJ, Morton A, Donato P, et al. 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48:477–82. https://doi.org/10.1007/s00259-020-04944-2.

CAS  Article  PubMed  Google Scholar 

Roberts MJ, Morton A, Papa N, et al. Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-05756-2.

Toriihara A, Nobashi T, Baratto L, et al. Comparison of 3 interpretation criteria for 68Ga- PSMA11 PET based on inter- and intrareader agreement. J Nucl Med. 2020;61:533–9. https://doi.org/10.2967/jnumed.119.232504.

CAS  Article  PubMed  Google Scholar 

Emmett LM, Papa N, Buteau J, et al. The PRIMARY Score: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. J Nucl Med Off Publ Soc Nucl Med. 2022. https://doi.org/10.2967/jnumed.121.263448.

de Feria Cardet RE, Hofman MS, Segard T, et al. Is prostate-specific membrane antigen positron emission tomography/computed tomography imaging cost-effective in prostate cancer: an analysis informed by the proPSMA trial. Eur Urol. 2021;79:413–8. https://doi.org/10.1016/j.eururo.2020.11.043.

CAS  Article  PubMed  Google Scholar 

Devos G, Vansevenant B, De Meerleer G, et al. Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review. World J Urol. 2021;39:3177–85. https://doi.org/10.1007/s00345-021-03611-x.

CAS  Article  PubMed  Google Scholar 

Tosco L, Laenen A, Gevaert T, et al. Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC Cancer. 2018;18:354 https://doi.org/10.1186/s12885-018-4275-z.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lenis AT, Pooli A, Lec PM, et al. Prostate-specific membrane antigen positron emission tomography/computed tomography compared with conventional imaging for initial staging of treatment-naïve intermediate- and high-risk prostate cancer: a retrospective single-center study. Eur Urol Oncol. 2020;18:S2588–9311. https://doi.org/10.1016/j.euo.2020.08.012. 30139-5

Article  Google Scholar 

Thalgott M, Düwel C, Rauscher I, et al. One-stop-shop whole-body 68Ga-PSMA-11 PET/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate cancer. J Nucl Med. 2018;59:1850–6. https://doi.org/10.2967/jnumed.117.207696.

CAS  Article  PubMed  Google Scholar